Common use of Screening, Day Clause in Contracts

Screening, Day. 7 to Day -1 Patients are admitted to the hospital for treatment of an AMI, prior to enrollment into the study. The treatment will include PCI with placement of a stent. After signing of Informed Consent, and prior to initiation of any study-related procedures, the following activities will be carried out: · confirmation of inclusion/exclusion criteria · negative pregnancy test for all women of child-bearing potential (as defined in Inclusion Criteria) · demographics · medical history · physical examination · vitals signs · 12-lead ECG, in supine position · blood and urine sampling for laboratory safety parameters (biochemistry, hematology and urinalysis) · blood sampling for Total CK/CK MB · blood sampling for NT-proBNP · echocardiography · MRI, if patient agrees · concomitant medication record (all currently prescribed and over the counter medications must be recorded in the Case Report Form [CRF], with dose and reason for use) · pre-device serious/adverse events